BRPI0408268A - moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoas - Google Patents

moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoas

Info

Publication number
BRPI0408268A
BRPI0408268A BRPI0408268-0A BRPI0408268A BRPI0408268A BR PI0408268 A BRPI0408268 A BR PI0408268A BR PI0408268 A BRPI0408268 A BR PI0408268A BR PI0408268 A BRPI0408268 A BR PI0408268A
Authority
BR
Brazil
Prior art keywords
methods
vivo
preventing
molecules
treating people
Prior art date
Application number
BRPI0408268-0A
Other languages
English (en)
Inventor
Maria M Mota
Ana Rodriguez
Silvia Giordano
Margarida Cunha Rodrigues
Original Assignee
Inst Gulbenkian De Ciencia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Gulbenkian De Ciencia filed Critical Inst Gulbenkian De Ciencia
Publication of BRPI0408268A publication Critical patent/BRPI0408268A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

"MOLECULAR E MéTODOS DE PREVENçãO OU INIBIçãO DA ATIVIDADE DA MALáRIA IN VIVO E DE TRATAMENTO DE PESSOAS". é provido método de prevenção da infecção de pessoas humanas por parasitas plasmódios. O método consiste na aplicação de compostos que interferem com a infecção de hepatócitos por Plasmodium viax.
BRPI0408268-0A 2003-03-12 2004-03-11 moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoas BRPI0408268A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45348303P 2003-03-12 2003-03-12
PCT/US2004/007516 WO2004080420A2 (en) 2003-03-12 2004-03-11 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists

Publications (1)

Publication Number Publication Date
BRPI0408268A true BRPI0408268A (pt) 2006-03-07

Family

ID=32990777

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408268-0A BRPI0408268A (pt) 2003-03-12 2004-03-11 moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoas

Country Status (8)

Country Link
US (1) US7670631B2 (pt)
EP (1) EP1601378A2 (pt)
JP (1) JP2007525428A (pt)
CN (1) CN1809382A (pt)
AP (1) AP2005003411A0 (pt)
BR (1) BRPI0408268A (pt)
WO (1) WO2004080420A2 (pt)
ZA (1) ZA200508178B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP2042181A1 (en) 2002-02-04 2009-04-01 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
GB2395432B (en) 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
CN1255106C (zh) * 2003-09-26 2006-05-10 李国桥 复方青蒿素
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US7566465B2 (en) * 2006-12-21 2009-07-28 The United States Of America As Represented By The Secretary Of The Army Artemisinins in the clinical and veterinary management of kinetoplastid infections
WO2008147826A1 (en) * 2007-05-22 2008-12-04 Seattle Biomedical Research Institute Malaria liver stage drugs
CA2714121C (en) 2008-02-05 2016-03-22 Forskarpatent I Syd Ab Selection of rna-aptamers as anti-malaria agents
US20110092452A1 (en) * 2008-03-05 2011-04-21 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating pancreatic cancer
IN2012DN01684A (pt) 2009-08-27 2015-06-05 U S A Represented By The Secretary Dept Of Health And Human Services
FR2952823B1 (fr) * 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
EP2512504A4 (en) * 2009-12-15 2013-06-19 Dec Int Nz Ltd COMPOSITION AND THERAPEUTIC METHOD
KR20130028058A (ko) * 2010-02-03 2013-03-18 엠이에이치 어소시에이츠, 인코포레이티드 선택적 및 생활성 동배체로서의 다수 치환된 플루오로메탄류
EP2404601A1 (en) * 2010-07-06 2012-01-11 BioAgency AG New drug combinations for the treatment of Malaria
WO2012135064A2 (en) * 2011-03-25 2012-10-04 The Regents Of The University Of California Attenuated strains of plasmodium
US9163044B2 (en) 2011-04-19 2015-10-20 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
WO2015006752A1 (en) * 2013-07-12 2015-01-15 The Regents Of The University Of California Combination therapies for malaria
WO2015178940A1 (en) * 2014-05-20 2015-11-26 American University Of Cairo (Auc) Ligands that target plasmodium sporozoite binding sites on cd81 and therapeutic methods using them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344321B1 (en) 1990-06-11 2002-02-05 Gilead Sciences, Inc. Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
US6214344B1 (en) 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
US6887499B2 (en) * 2000-05-22 2005-05-03 Enitan A. Bababunmi Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease

Also Published As

Publication number Publication date
ZA200508178B (en) 2007-04-25
WO2004080420A3 (en) 2004-11-25
WO2004080420A2 (en) 2004-09-23
CN1809382A (zh) 2006-07-26
EP1601378A2 (en) 2005-12-07
JP2007525428A (ja) 2007-09-06
US7670631B2 (en) 2010-03-02
AP2005003411A0 (en) 2005-12-31
US20040185050A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
BRPI0408268A (pt) moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoas
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
GB0223040D0 (en) Therapeutic compounds
ES2414872T8 (es) Terapia combinada para la prevención o tratamiento de la enfermedad de Alzheimer y kit correspondiente
DE60114808D1 (de) Oberflächenbehandlung von medizinischer vorrichtung
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
PL372925A1 (en) Prevention and treatment of restenosis by local administration of drug
IL162505A0 (en) Method for treatment of peripheral neural and vascular ailments
BRPI0407950A (pt) processo para a preparação de uma composição de higiene pessoal
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
MY138883A (en) Use of asiatic acid for treatment of cencer
BRPI0408491A (pt) tratamento da doença de alzheimer
GB0020504D0 (en) Therapeutic method
DE60002226D1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte
CY1110043T1 (el) 2-αμινοβενζουλ παραγωγα
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
EE200300328A (et) IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
PL373528A1 (en) Medicine for preventing and treating bromidrosis
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
BR9908716A (pt) Tratamento de disfunção sexual em certos grupos de pacientes
EP1547594A4 (en) MEANS FOR THE PREVENTION OR TREATMENT OF DECUBITUS
BR0213479A (pt) Utilização do irbesartan para a preparação de medicamentos úteis para a prevenção ou o tratamento da hipertensão pulmonar
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
PT1133296E (pt) Nova aplicacao terapeutica da nicergolina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.